Molecular Biology of Pathogens Laboratory, Biotechnology Center, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
mBio. 2021 Mar 9;12(2):e03457-20. doi: 10.1128/mBio.03457-20.
is a ubiquitous, opportunistic fungal pathogen that kills almost 200,000 people worldwide each year. It is acquired when mammalian hosts inhale the infectious propagules; these are deposited in the lung and, in the context of immunocompromise, may disseminate to the brain and cause lethal meningoencephalitis. Once inside the host, undergoes a variety of adaptive processes, including secretion of virulence factors, expansion of a polysaccharide capsule that impedes phagocytosis, and the production of giant (Titan) cells. The transcription factor Pdr802 is one regulator of these responses to the host environment. Expression of the corresponding gene is highly induced under host-like conditions and is critical for dissemination and virulence in a mouse model of infection. Direct targets of Pdr802 include the quorum sensing proteins Pqp1, Opt1, and Liv3; the transcription factors Stb4, Zfc3, and Bzp4, which regulate cryptococcal brain infectivity and capsule thickness; the calcineurin targets Had1 and Crz1, important for cell wall remodeling and virulence; and additional genes related to resistance to host temperature and oxidative stress, and to urease activity. Notably, cryptococci engineered to lack Pdr802 showed a dramatic increase in Titan cells, which are not phagocytosed and have diminished ability to directly cross biological barriers. This explains the limited dissemination of mutant cells to the central nervous system and the consequently reduced virulence of this strain. The role of Pdr802 as a negative regulator of Titan cell formation is thus critical for cryptococcal pathogenicity. The pathogenic yeast presents a worldwide threat to human health, especially in the context of immunocompromise, and current antifungal therapy is hindered by cost, limited availability, and inadequate efficacy. After the infectious particle is inhaled, initiates a complex transcriptional program that integrates cellular responses and enables adaptation to the host lung environment. Here, we describe the role of the transcription factor Pdr802 in the response to host conditions and its impact on virulence. We identified direct targets of Pdr802 and also discovered that it regulates cellular features that influence movement of this pathogen from the lung to the brain, where it causes fatal disease. These findings significantly advance our understanding of a serious disease.
新生隐球菌是一种无处不在的机会性病原体真菌,每年在全球范围内导致近 20 万人死亡。哺乳动物宿主吸入传染性繁殖体后即可感染该病原体;这些繁殖体沉积在肺部,在免疫功能受损的情况下,可能会传播到大脑并导致致命性脑膜脑炎。一旦进入宿主,新生隐球菌就会经历多种适应性过程,包括分泌毒力因子、扩大阻碍吞噬作用的多糖荚膜,并产生巨型(泰坦)细胞。转录因子 Pdr802 是宿主环境下这些反应的一个调节因子。在类似宿主的条件下,相应基因的表达高度诱导,对于感染小鼠模型中的传播和毒力至关重要。Pdr802 的直接靶标包括群体感应蛋白 Pqp1、Opt1 和 Liv3;转录因子 Stb4、Zfc3 和 Bzp4,它们调节隐球菌的脑感染性和荚膜厚度;钙调神经磷酸酶靶标 Had1 和 Crz1,对细胞壁重塑和毒力很重要;以及与宿主温度和氧化应激抗性以及脲酶活性相关的其他基因。值得注意的是,缺乏 Pdr802 的新生隐球菌工程菌株显示出泰坦细胞的显著增加,这些细胞不能被吞噬,并且直接穿过生物屏障的能力降低。这解释了突变细胞向中枢神经系统的有限传播以及该菌株毒力的降低。因此,Pdr802 作为泰坦细胞形成的负调节剂在隐球菌致病性中起着至关重要的作用。致病性酵母新生隐球菌对人类健康构成了全球性威胁,尤其是在免疫功能受损的情况下,而目前的抗真菌治疗受到成本、可用性有限和疗效不足的限制。感染颗粒被吸入后,新生隐球菌会启动一个复杂的转录程序,该程序整合细胞反应并使适应宿主肺部环境。在这里,我们描述了转录因子 Pdr802 在宿主条件反应中的作用及其对毒力的影响。我们确定了 Pdr802 的直接靶标,并发现它还调节影响该病原体从肺部向大脑移动的细胞特征,在大脑中它会导致致命疾病。这些发现大大提高了我们对严重疾病的认识。